Adoptive transfer of tumor specific T cells from allogeneic donors is feasible, effective and safe alternative to autologous T cell based tumor immunotherapy. JMS [Internet]. 2014 Mar. 30 [cited 2025 Aug. 18];83(1):21-8. Available from: https://horkruks.ump.edu.pl/index.php/JMS/article/view/39